Johnson & Johnson (JNJ)
163.04 -0.25 (-0.15%) 09:35 ET [NYSE]
163.01 x 100 163.29 x 100
Realtime by (Cboe BZX)
163.01 x 100 163.29 x 100
Realtime 163.41 +0.12 (+0.07%) 09:06 ET
for Tue, Mar 25th, 2025
Results
download Want to compare other data? Select Fields| Symbol | JNJ | LLY | ABBV | ||
| Company | Johnson & Johnson | Eli Lilly and Company | Abbvie Inc | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 163.41 | 867.00 | 209.03 | ||
| High | 163.41 | 867.00 | 209.03 | ||
| Low | 163.41 | 867.00 | 209.03 | ||
| Last | 163.04 | 871.66 | 207.91 | ||
| Change | -0.25 | +6.76 | -1.26 | ||
| % Change | -0.15% | +0.78% | -0.60% | ||
| Volume | 3,481 | 5,057 | 1,548 | ||
| 20-Day Average Volume | 8,946,534 | 3,516,063 | 6,625,063 | ||
| Previous Close | 163.29 | 864.90 | 209.17 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 164.39 | 864.04 | 210.96 | ||
| 20-Day Raw Stochastic | 25.98% | 51.07% | 44.11% | ||
| 20-Day Relative Strength | 56.92% | 53.92% | 59.48% | ||
| Weighted Alpha | +6.17 | +9.93 | +20.18 | ||
| Today's Opinion | 72% Buy | 40% Buy | 88% Buy | ||
| Previous Opinion | 56% Buy | 24% Buy | 88% Buy | ||
| Last Month's Opinion | 40% Buy | 24% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.51% since 03/18/25 | +5.41% since 03/18/25 | -2.25% since 03/18/25 | ||
| Low | 161.93 on 03/20/25 | 819.50 on 03/19/25 | 207.50 on 03/24/25 | ||
| High | 164.39 on 03/24/25 | 867.00 on 03/25/25 | 214.50 on 03/19/25 | ||
| 1-Month | |||||
| %Chg | -1.61% since 02/25/25 | -3.86% since 02/25/25 | +2.40% since 02/25/25 | ||
| Low | 161.10 on 03/14/25 | 795.38 on 03/13/25 | 201.43 on 02/26/25 | ||
| High | 169.99 on 03/04/25 | 935.63 on 03/03/25 | 218.66 on 03/10/25 | ||
| 3-Month | |||||
| %Chg | +12.04% since 12/24/24 | +8.96% since 12/24/24 | +16.13% since 12/24/24 | ||
| Low | 140.68 on 01/10/25 | 725.01 on 01/17/25 | 168.06 on 01/22/25 | ||
| High | 169.99 on 03/04/25 | 935.63 on 03/03/25 | 218.66 on 03/10/25 | ||
| 6-Month | |||||
| %Chg | +1.75% since 09/25/24 | -6.23% since 09/25/24 | +9.29% since 09/25/24 | ||
| Low | 140.68 on 01/10/25 | 711.40 on 11/18/24 | 163.81 on 11/19/24 | ||
| High | 169.99 on 03/04/25 | 937.00 on 10/14/24 | 218.66 on 03/10/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 393,504,032 | 820,072,256 | 369,259,264 | ||
| Shares Outstanding, K | 2,409,848 | 948,170 | 1,765,355 | ||
| Annual Sales | 88,821,000,000 | 45,042,700,000 | 56,334,000,000 | ||
| Annual Net Income | 14,066,000,000 | 10,590,000,000 | 4,278,000,000 | ||
| Last Quarter Sales | 22,520,000,000 | 13,532,800,000 | 15,102,000,000 | ||
| Last Quarter Net Income | 3,431,000,000 | 4,409,800,000 | -22,000,000 | ||
| 60-Month Beta | 0.47 | 0.34 | 0.61 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.04 on 01/22/25 | 5.32 on 02/06/25 | 2.16 on 01/31/25 | ||
| Latest Earnings Date | 04/15/25 | 04/29/25 | 04/25/25 | ||
| Most Recent Dividend | 1.240 on 02/18/25 | 1.500 on 02/14/25 | 1.640 on 01/15/25 | ||
| Next Ex-Dividends Date | 02/18/25 | 02/14/25 | 04/15/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 16.38 | 64.43 | 20.75 | ||